Nondeletional α-
globin mutations are known to cause more serious clinical effects than deletional ones. A rare IVS-I-1 (G>A) (HBA2: c.95+1G>A) donor splice site mutation interferes with normal splicing of
pre mRNA and results in activation of a
cryptic splice site as well as a frameshift mutation.
Hb Adana [HBA2: c.179G>A (or
HBA1)] is a highly unstable variant
hemoglobin (Hb) resulting from a mutation at
codon 59 on the HBA2 or
HBA1 gene, recognized to cause severe α-
thalassemia (α-thal) syndromes. We report a unique case of compound heterozygosity for these two mutations in a 9-year-old boy who presented with a Hb level of 5.3 g/dL and
hepatomegaly at the age of 15 months. He required regular
blood transfusions in view of a Hb level of <7.0 g/dL and
failure to thrive. He had thalassemic red cell indices and peripheral blood film. The Hb electrophoresis only showed a raised Hb F level (3.3%) and a pre run peak but the Hb H inclusion test was negative. His father had thalassemic red cell indices but a normal Hb level. His mother had almost normal Hb levels and red cell indices.
Hb Adana involving the HBA2 gene was detected by mutiplex amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) in the proband and his father.
DNA sequencing of the HBA2 gene confirmed the IVS-I-1 mutation in the proband and his mother. This case highlighted the unique interaction of the IVS-I-1 mutation with
Hb Adana in a young Malay boy presenting with transfusion-dependent α-thal.